Cited by

• Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.

  Grottoli S, Arvat E, Gauna C, Maccagno B, Ramunni J, Giordano R, Maccario M, Deghenghi R, Ghigo E. Grottoli S, et al. Pituitary. 1999 Nov;2(3):197-204. doi: 10.1023/a:1009992909247. Pituitary. 1999. PMID: 11081154 Clinical Trial.
• Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.

  Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R. Vicennati V, et al. J Endocrinol Invest. 2004 Jun;27(6):541-7. doi: 10.1007/BF03347476. J Endocrinol Invest. 2004. PMID: 15717651 Clinical Trial.
• Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.

  Pivonello R, Faggiano A, Filippella M, Di Somma C, De Martino MC, Gaccione M, Lombardi G, Colao A. Pivonello R, et al. J Endocrinol Invest. 2002 Dec;25(11):932-7. doi: 10.1007/BF03344064. J Endocrinol Invest. 2002. PMID: 12553551
• Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone.

  Kübler A, Rothacher G, Knappertz VA, Krämer G, Nink M, Beyer J, Lehnert H. Kübler A, et al. Clin Investig. 1994 May;72(5):331-6. doi: 10.1007/BF00252822. Clin Investig. 1994. PMID: 8086764
• Corticotropin-releasing hormone receptor-1 and 2 activity produces divergent resistance against stress-induced pulmonary Streptococcus pneumoniae infection.

  Kim BJ, Kayembe K, Simecka JW, Pulse M, Jones HP. Kim BJ, et al. J Neuroimmunol. 2011 Aug 15;237(1-2):57-65. doi: 10.1016/j.jneuroim.2011.06.016. Epub 2011 Jul 20. J Neuroimmunol. 2011. PMID: 21774994 Free PMC article.